Margaret Charpentier, Pharm.D., BCPS, CDOE

  • Clinical Professor
  • Office: 244H
  • Phone: 401.874.5004
  • Email: chaps@uri.edu
  • Office Location: Avedisian Hall, 7 Greenhouse Road, Kingston, RI 02881

Biography

Dr. Charpentier began at URI in 1990, when she worked in elderly outreach. In 1991, she attended URI to obtain her PharmD. She returned to URI in 1999, after working in hospital practice, managed care and in oncology research. She was hired to coordinate the Non traditional PharmD practice experiences, and had the privilege of working with pharmacists throughout the state and region while they achieved their PharmD.

Currently Dr. Charpentier coordinates the hematology oncology therapeutics core in the P3 spring semester. Her areas of interest include medicine, oncology, supportive and palliative care, and diabetes. Dr. Charpentier also teaches Interactive learning (IAL) in the gastrointestinal/endocrine core, coordinates and teaches the hematology/oncology IAL.

Dr Charpentier is a clinical pharmacist at Roger Williams Medical Center in Providence RI. Her advanced practice rotation is in adult internal medicine. Students round on the interdisciplinary medicine teams daily. Dr. Charpentier serves as an educator and model to students, medical staff and pharmacy staff. Dr. Charpentier is a member of the RISHP, hematology/oncology pharmacist association, ACCP, Board of Directors for GAIA Vaccine Foundation. She has volunteered at RI Free Cinic, Clinica Esperanza, and has been involved in Hospice for Hope’s programs in Romania.

Research

Oral cancer therapy, supportive care, teaching.

Education

Bachelor of Science in Pharmacy, University of Rhode Island, 1987
Doctor of Pharmacy, University of Rhode Island

Selected Publications

Charpentier, MM, Orr, KK, Taveira, TH. Improving pharmacist knowledge of oral chemotherapy in the community. Ann Pharmacother (2012). Manuscript in press.

Ingemi, AI, Bota, VM, Peguero, A, Charpentier, MM. Fanconi’s Syndrome and Nephrogenic Diabetes Insipidus in an Adult Patient Treated with Ifosfamide. Pharmacotherapy. Jan;32(1)( 2012);e12-6. doi: 10.1002/PHAR.1013

Schwartz, J, Charpentier, MM. Bevacizumab in Metastatic Breast Cancer: Is This the End of the Line? The Oncology Pharmacist. November (2011).

Charpentier, MM and Bundeff, A. Hypertension and the very elderly. Ann Pharmacother 2011:45: 1138-43. Charpentier, M. Antioxidants and cancer therapy. Pharmacy Today. November 2007 13(11):20.

Charpentier, M. Efaproxiral: A radiation Enhancer Used in Brain Metastases from Breast Cancer. Ann Pharmacother. 2005 Dec 39(12):2038-45. Epub 2005 Oct 25.

Strong KM , Charpentier MM Traditional and Newer Therapies for Glaucoma. U.S. Pharmacist. 2002;27(5):85-94.